Amy Vaughan Dermatology Introduces Advanced Nonsurgical Skin Cancer Treatment in West Virginia

Amy Vaughan Dermatology Leads with Nonsurgical Skin Cancer Treatment

In a groundbreaking development for skin cancer treatment, Amy Vaughan Dermatology, located in Barboursville, West Virginia, has become the first in the state to offer a pioneering nonsurgical option known as GentleCure®. This innovative treatment is part of a broader move toward minimally invasive healthcare options and has the potential to significantly enhance patient outcomes.

The introduction of Image-Guided Superficial Radiation Therapy (IGSRT) is designed specifically for treating nonmelanoma skin cancer, including basal and squamous cell carcinomas. Utilizing ultrasound imaging, IGSRT directs low-level x-rays precisely to affected areas of the skin, effectively targeting cancerous cells while minimizing damage to surrounding healthy tissue. Importantly, studies demonstrate a cure rate exceeding 99% for patients treated with this method, marking it as an equivalently effective alternative to traditional procedures like Mohs surgery.

Dr. Amy Vaughan, the founder of Amy Vaughan Dermatology, expressed her enthusiasm about providing such an advanced treatment to the local community. According to Dr. Vaughan, “Over 21,000 individuals are predicted to be diagnosed with nonmelanoma skin cancer in West Virginia this year. With sun exposure as the primary risk factor, having a safe, effective treatment option is crucial.” The clinic’s introduction of GentleCure® not only addresses a significant healthcare need but also empowers patients with choices about how they can approach their treatment.

During the announcement event, Dr. Vaughan was joined by local dignitaries, including Barboursville Mayor Chris Tatum, Cabell County Commission President Liza Caldwell, and Joslyn Barnhart, Public Information Officer for U.S. Senator Jim Justice. This broad community support underscores the significance of this new treatment option. Kim Messer, a patient already benefiting from IGSRT at Dr. Vaughan's clinic, shared her positive experience during video remarks at the presentation.

In comments about the partnership with Amy Vaughan Dermatology, Kerwin Brandt, CEO of SkinCure Oncology, highlighted the importance of expanding access to effective cancer treatments. “It is vital for patients everywhere to have the option to treat their nonmelanoma skin cancer non-invasively,” Brandt stated. This partnership reflects SkinCure's commitment to bringing sophisticated cancer treatment options to private practices, making them more readily available to patients in need.

The GentleCure® treatment is provided in a supportive environment, aligned with patient comfort and care. The modern approach aims to alleviate some of the stress and anxiety associated with traditional surgical treatments for cancer. With a national network of about 500 physicians, SkinCure Oncology has treated over 140,000 patients, indicating a robust trust in this innovative treatment model.

Looking toward the future, Amy Vaughan Dermatology is poised to set a precedent in West Virginia, paving the way for additional clinics to offer similarly advanced nonsurgical treatments. The anticipated impact of GentleCure® will not only improve patient outcomes but also educate the community about the importance of early detection and treatment of skin cancers.

As awareness about skin cancer continues to grow, initiatives like Amy Vaughan Dermatology's GentleCure® experience reflect the essential advancements in the field of dermatology. For those facing a diagnosis of nonmelanoma skin cancer, the arrival of this nonsurgical treatment option could mean a transformative step toward recovery without the burden of invasive procedures.

For more information about this and other treatment options, visit SkinCureOncology.com or GentleCure.com for patient resources and support.